Patents by Inventor Jane Ryan
Jane Ryan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 9206171Abstract: This invention relates to antiviral agents, in particular to salts useful in the treatment of infections caused by Picornaviridae, such as human rhinovirus (HRV) and methods for their preparation. In one embodiment, the invention relates to a bis-dihydrogenphophate salt having the formula: The invention also relates to the use of these salts in the treatment of picornavirus infections. The salts of this invention are especially suitable for use in the treatment of HRV, however it is to be understood that the invention is also applicable to other viruses of the picornavirus family.Type: GrantFiled: September 10, 2013Date of Patent: December 8, 2015Assignee: BIOTA SCIENTIFIC MANAGEMENT PTY LTDInventors: Jane Ryan, Margaret Anne Butt
-
Publication number: 20140179710Abstract: This invention relates to antiviral agents, in particular to salts useful in the treatment of infections caused by Picornaviridae, such as human rhinovirus (HRV) and methods for their preparation. The invention also relates to the use of these salts in the treatment of picornavirus infections. The salts of this invention are especially suitable for use in the treatment of HRV, however it is to be understood that the invention is also applicable to other viruses of the picornavirus family.Type: ApplicationFiled: September 10, 2013Publication date: June 26, 2014Applicant: Biota Scientific Management Pty Ltd.Inventors: Jane Ryan, Margaret Anne Butt
-
Patent number: 8580791Abstract: Novel acid addition salts of 6-{2-[1-(6-methyl-3-pyridazinyl)-4-piperidinyl]ethoxy}-3-ethoxy-1,2-benzisoxazole of following formula are disclosed, particularly a crystalline form of a bis-dihydrogenphosphate salt: Such compounds have particular advantages with regard to treatment of picornaviruses. Related pharmaceutical compositions and methods of treating a picornavirus infection are also disclosed.Type: GrantFiled: May 27, 2009Date of Patent: November 12, 2013Assignee: Biota Scientific Management Pty LtdInventors: Jane Ryan, Margaret Anne Butt
-
Publication number: 20110257192Abstract: The present invention relates to the treatment, alleviation, prevention or reduction of symptoms or exacerbations of asthma or chronic obstructive pulmonary disease (COPD), of which reduced lung function is typically symptomatic.Type: ApplicationFiled: April 15, 2011Publication date: October 20, 2011Applicant: BIOTA SCIENTIFIC MANAGEMENT PTY LTDInventors: John Nicholas Lambert, Jane Ryan, Janet Marie Wilson
-
Publication number: 20110144118Abstract: This invention relates to antiviral agents, in particular to salts useful in the treatment of infections caused by Picornaviridae, such as human rhinovirus (HRV) and methods for their preparation. The invention also relates to the use of these salts in the treatment of picornavirus infections. The salts of this invention are especially suitable for use in the treatment of HRV, however it is to be understood that the invention is also applicable to other viruses of the picornavirus family.Type: ApplicationFiled: May 27, 2009Publication date: June 16, 2011Applicant: BIOTA SCIENTIFIC MANAGEMENT PTY LTDInventors: Jane Ryan, Margaret Anne Butt
-
Publication number: 20050221285Abstract: Anti-viral agents which may be effective for treating, for example, respiratory infections by Respiratory Syncytial Virus (RSV). A three-dimensional structure model of the RSV-F protein has been generated and described which can be used to identify, screen, and/or develop anti-viral agents, including RSV neutralising antibodies. The structure model may also be used to develop RSV-binding antibodies useful for diagnostic assays.Type: ApplicationFiled: November 8, 2002Publication date: October 6, 2005Applicant: Biota Holdings Ltd.Inventors: Craig Morton, Michael Parker, Jane Ryan
-
Patent number: 6800184Abstract: A system for separating biomolecules by electrophoretic separation including a first separation barrier having a defined molecular mass cut-off disposed in the first electric field area, a first restriction barrier disposed between a first cathode zone and a first separation barrier so as to define a first interstitial volume therebetween, a second restriction barrier disposed between the first anode zone and the first separation barrier so as to define a second interstitial volume therebetween, and a pumping means to provide a sample constituent in a selected one of the first interstitial and second interstitial volumes wherein upon application of the first voltage potential, a selected separation product is removed from the sample constituent through the first separation barrier and provided to the other of the first and second interstitial volumes.Type: GrantFiled: April 18, 2001Date of Patent: October 5, 2004Assignee: Gradipore, LimitedInventors: Brendon Francis Conlan, Andrew Mark Gilbert, Chenicheri Hariharan Nair, Lucy Jane Ryan, Dennis Brian Rylatt, Theresa Marie Thomas
-
Patent number: 6660150Abstract: An apparatus and method for the separation of molecules having a molecular mass from about 200 to 5000 Da, particularly micromolecules having a molecular mass of less than 5000 Dalton. The apparatus contains an anode, a cathode disposed between the anode and the separation membrane that defines a first interstitial volume therebetween. A first restriction membrane disposed between the anode and the separation membrane defines a second interstitial volume therebetween. Upon application of the voltage potential, a selected separation product is removed from the sample constituent through the separation membrane, and provided to the other of the first and second interstitial volumes.Type: GrantFiled: April 13, 2001Date of Patent: December 9, 2003Assignee: Gradipore LimitedInventors: Brendon Francis Conlan, Andrew Mark Gilbert, Lucy Jane Ryan, Chenicheri Hariharan Nair
-
Publication number: 20030047455Abstract: The claims describe methods and apparatus for obtaining a target component from a milk source using a membrane-based electrophoresis separation system. They may also be used in conjunction with or as a substitute for one or more steps in a conventional purification scheme for obtaining target component from a milk source.Type: ApplicationFiled: August 6, 2002Publication date: March 13, 2003Applicant: Gradipore LimitedInventors: Lucy Jane Ryan, Stewart Andrew Smith, Elizabeth Jean Seabrook, Philip John Roeth
-
Publication number: 20030029725Abstract: This invention is directed to an apparatus and method for the separation of molecules, particularly micromolecules having a molecular mass of less than 5000 Dalton.Type: ApplicationFiled: October 7, 2002Publication date: February 13, 2003Inventors: Brendon Francis Conlan, Andrew Mark Gilbert, Lucy Jane Ryan, Chenicheri Hariharan Nair
-
Publication number: 20020148730Abstract: This invention is directed to an apparatus and method for the separation of molecules, particularly micromolecules having a molecular mass of less than 5000 Dalton.Type: ApplicationFiled: April 13, 2001Publication date: October 17, 2002Inventors: Brendon Francis Conlan, Andrew Mark Gilbert, Lucy Jane Ryan, Chenicheri Hariharan Nair
-
Publication number: 20010053537Abstract: A system for separating small macromolecules by electrophoresis, the system comprising:Type: ApplicationFiled: April 18, 2001Publication date: December 20, 2001Inventors: Brendon Francis Conlan, Andrew Mark Gilbert, Chenicheri Hariharan Nair, Lucy Jane Ryan, Dennis Brian Rylatt, Theresa Marie Thomas
-
Patent number: 5426097Abstract: The subject invention provides a pharmaceutical composition, which comprises an amount of calreticulin effective for blocking or preventing thrombosis in a subject, causing substantially no defect or no defect in normal hemostasis, and a pharmaceutically effective carrier. The subject invention provides a method for blocking or preventing thrombosis in a subject, causing substantially no defect or no defect in normal hemostasis, which method comprises administering calreticulin to the subject in an amount effective for blocking or preventing thrombosis. The subject invention provides a pharmaceutical composition, which comprises calreticulin in combination with an other antithrombotic agent, in an amount and proportion effective for enhancing the action of the other antithrombotic agent, to prevent clotting or dissolve clots which have already formed.Type: GrantFiled: April 6, 1993Date of Patent: June 20, 1995Assignees: The Trustees of Columbia University in the City of New York, Board of Regents, The University of Texas SystemInventors: David M. Stern, Keisuke Kuwabara, Claude Benedict, Jane Ryan
-
Patent number: 5337632Abstract: An opener, especially for opening tab-top beverage containers and certain vehicle door handle systems has an essentially flat, rectangular handle portion with a curved tail end and a hook disposed at an opposite end of the handle portion. The inventive opener simplifies the tasks of opening tab-top beverage containers end certain vehicle door handle systems, while protecting a user's hands and fingernails.Type: GrantFiled: June 28, 1993Date of Patent: August 16, 1994Assignee: Nailco, Inc.Inventors: Donald L. Thomas, Jane Ryan